1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:


Clear current filters  or Add more filters

View Option


Results 31-40 of 67 (Search time: 0.003 seconds).

  Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile (Journal article)

  Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular risk (Journal article)

  The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)

  The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia (Journal article)

  The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia (Journal article)

  The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed Hyperlipidemia (Journal article)

  Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic Syndrome (Journal article)

  Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia (Journal article)

  Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: Where we are now? (Journal article)